Patients carrying variants in these genes may have significantly higher weight regain risk after stopping semaglutide, meaning longer-term or indefinite therapy could be medically appropriate
Hunot S, Brugg B, Ricard D, Michel PP, Muriel MP, Ruberg M, et al
Andrea Dunaif, chief of the division of endocrinology, diabetes and bone disease for the Mount Sinai Health System, tells Yahoo
Boost your body's natural defenses with this pure, non-GMO L-Glutathione supplement
Patients with obesity and diabetes who were not on GLP-1 receptor agonists also had residual gastric contents at an alarmingly high rate
Back Brandt, SJ, Mller, TD, DiMarchi, RD, et al (12 Sept 2018) 'Peptide-based multi-agonists: a new paradigm in metabolic pharmacology', Journal of Internal Medicine